Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Esomeprazole on Glycaemic Regulation in Type 2 Diabetes
NCT03598738Completed
- Sponsor
- Baskent University Ankara Hospital
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
01
Overview
Open-label trial of esomeprazole in type 2 diabetes mellitus (T2DM), sponsored by Baskent University Ankara Hospital. Primary endpoint: Hemoglobin A1c at 3 months. Started Dec 2015; status: completed.
02
Drugs
esomeprazole
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03598738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03598738.